Skip to main content

Table 1 Patients demographic data

From: A comparison of ondansetron and lidocaine in reducing injection pain of propofol: a randomized controlled study

 

Group O (n = 80)

Group L (n = 80)

Group C (n = 80)

P-value

Age (years); median(IQR)

52 (42.8–57.0)

49.5 (38.8–57.0)

47.5 (32.0–58.0)

0.199

Gender

  Male; n (%)

22 (27.5)

24 (30.0)

22 (27.5)

0.921

  Female; n (%)

58 (72.5)

56 (70.0)

58 (72.5)

 

Weight (kg.); median (IQR)

63.5 (56.8–70.0)

65.5 (60.0–71.2)

66 (57.8–74.0)

0.255

Height (cm.); mean (SD)

159.3 (± 8.7)

160.9 (± 7)

160.8 (± 8.9)

0.406

BMI (kg/m2); median (IQR)

25.1 (22.8–28.2)

26.2 (23.3–28.5)

24.9 (22.7–29.2)

0.618

ASA Classification; n (%)

  ASA class I

10 (12.5)

12 (15.0)

11 (13.8)

 

  ASA class II

60 (75.0)

56 (70.0)

58 (72.5)

0.973

  ASA class III

10 (12.5)

12 (15.0)

11 (13.8)

 

Baseline; median (IQR)

  Pulse rate (bpm)

72.5 (65.8–84.0)

75.0 (67.0–85.0)

75.0 (65.0–83.5)

0.665

  SBP (mmHg.)

138.5 (125.8–158.2)

145.0 (128.0–160.2)

134.5 (120.0–155.0)

0.247

  DBP (mmHg.)

80.0 (70.0–88.2)

81.5 (72.0–90.0)

77.0 (70.0–83.2)

0.066

  MAP (mmHg.)

96.5 (87.0–110.0)

101.0 (91.8–109.2)

95.0 (85.8–102.2)

0.046

Before induction; median (IQR)

  Pulse rate (bpm.)

70.0 (62.0–81.2)

70.0 (63.8–80.0)

70.0 (60.0–87.2)

0.878

  SBP (mmHg.)

121.0 (105.0–140.0)

117.0 (105.0–131.2)

119.5 (96.0–140.0)

0.378

  DBP (mmHg.)

78.0 (60.0–85.0)

70.0 (60.0–81.0)

70.0 (55.0–80.0)

0.295

  MAP (mmHg.)

87.5 (74.8–100.2)

82.0 (74.0–95.2)

87.5 (66.0–100.0)

0.472

After intubation; median (IQR)

  Pulse rate (bpm.)

76.5 (67.8–85.0)

83.0 (70.0–95.0)

75.0 (67.8–88.2)

0.027

  SBP (mmHg.)

136.0 (123.8–160.8)

140.0 (123.8–168.8)

130.5 (112.5–155.2)

0.071

  DBP (mmHg.)

80.0 (73.5–95.0)

84.0 (67.8–101.2)

78.0 (64.8–90.0)

0.066

  MAP (mmHg.)

98.0 (87.5–113.2)

102.5 (85.0–122.0)

92.5 (78.8–107.2)

0.012